

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exocrine pancreas development (GO:0031017) | 9.31613331 |
| 2 | barbed-end actin filament capping (GO:0051016) | 9.27065139 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 7.96869270 |
| 4 | regulation of respiratory burst (GO:0060263) | 7.90533637 |
| 5 | cellular response to cadmium ion (GO:0071276) | 7.67125852 |
| 6 | opsonization (GO:0008228) | 7.18869005 |
| 7 | positive regulation of macrophage cytokine production (GO:0060907) | 6.96542723 |
| 8 | male sex determination (GO:0030238) | 6.79099106 |
| 9 | protein heterotetramerization (GO:0051290) | 6.67711597 |
| 10 | keratan sulfate catabolic process (GO:0042340) | 5.93726673 |
| 11 | positive regulation of glycolytic process (GO:0045821) | 5.81481758 |
| 12 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 5.52863732 |
| 13 | inositol phosphate dephosphorylation (GO:0046855) | 5.52863732 |
| 14 | positive regulation of glycogen biosynthetic process (GO:0045725) | 5.47362946 |
| 15 | response to folic acid (GO:0051593) | 5.34155680 |
| 16 | inositol phosphate catabolic process (GO:0071545) | 5.06016610 |
| 17 | necroptotic process (GO:0070266) | 4.94156094 |
| 18 | dermatan sulfate biosynthetic process (GO:0030208) | 4.83956776 |
| 19 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.78481715 |
| 20 | positive regulation of glycogen metabolic process (GO:0070875) | 4.71162999 |
| 21 | positive regulation of smoothened signaling pathway (GO:0045880) | 4.67637720 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.53777092 |
| 23 | regulation of macrophage cytokine production (GO:0010935) | 4.50517217 |
| 24 | nucleoside diphosphate catabolic process (GO:0009134) | 4.46404081 |
| 25 | dermatan sulfate metabolic process (GO:0030205) | 4.43591729 |
| 26 | actin filament capping (GO:0051693) | 4.32373347 |
| 27 | activation of protein kinase B activity (GO:0032148) | 4.14199907 |
| 28 | protein heterotrimerization (GO:0070208) | 4.02121038 |
| 29 | negative regulation of actin filament depolymerization (GO:0030835) | 3.86118979 |
| 30 | glomerulus development (GO:0032835) | 3.75587113 |
| 31 | modulation by virus of host morphology or physiology (GO:0019048) | 3.68318043 |
| 32 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.68113738 |
| 33 | defense response to fungus (GO:0050832) | 3.63655138 |
| 34 | sex determination (GO:0007530) | 3.62472548 |
| 35 | chondroitin sulfate catabolic process (GO:0030207) | 3.59799184 |
| 36 | regulation of female receptivity (GO:0045924) | 3.58186126 |
| 37 | mitotic cytokinesis (GO:0000281) | 3.56296886 |
| 38 | response to prostaglandin E (GO:0034695) | 3.51397932 |
| 39 | myeloid leukocyte mediated immunity (GO:0002444) | 3.43937694 |
| 40 | definitive hemopoiesis (GO:0060216) | 3.43652592 |
| 41 | keratan sulfate biosynthetic process (GO:0018146) | 3.42603376 |
| 42 | sulfur compound catabolic process (GO:0044273) | 3.37894580 |
| 43 | keratan sulfate metabolic process (GO:0042339) | 3.30217367 |
| 44 | positive regulation of prostaglandin secretion (GO:0032308) | 3.29227088 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13410663 |
| 46 | programmed necrotic cell death (GO:0097300) | 3.08378018 |
| 47 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.06065502 |
| 48 | regulation of glycolytic process (GO:0006110) | 2.98069894 |
| 49 | positive regulation of viral genome replication (GO:0045070) | 2.96361287 |
| 50 | regulation of actin filament depolymerization (GO:0030834) | 2.94503761 |
| 51 | positive regulation of interleukin-17 production (GO:0032740) | 2.92183711 |
| 52 | phospholipid dephosphorylation (GO:0046839) | 2.90333757 |
| 53 | female mating behavior (GO:0060180) | 2.88756800 |
| 54 | necrotic cell death (GO:0070265) | 2.88566227 |
| 55 | negative regulation of actin filament polymerization (GO:0030837) | 2.88280515 |
| 56 | mitochondrial calcium ion transport (GO:0006851) | 2.80917555 |
| 57 | oligodendrocyte development (GO:0014003) | 2.80685061 |
| 58 | drug transmembrane transport (GO:0006855) | 2.78483487 |
| 59 | regulation of prostaglandin secretion (GO:0032306) | 2.78269850 |
| 60 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.77572987 |
| 61 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.77546633 |
| 62 | regulation of plasminogen activation (GO:0010755) | 2.77012519 |
| 63 | indolalkylamine metabolic process (GO:0006586) | 2.76458227 |
| 64 | polyol catabolic process (GO:0046174) | 2.75315806 |
| 65 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.75122898 |
| 66 | keratinocyte development (GO:0003334) | 2.74458538 |
| 67 | response to prostaglandin (GO:0034694) | 2.71619987 |
| 68 | lateral sprouting from an epithelium (GO:0060601) | 2.69458028 |
| 69 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.68371476 |
| 70 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.68051001 |
| 71 | positive regulation of glucose import (GO:0046326) | 2.64773555 |
| 72 | positive regulation of cell-substrate adhesion (GO:0010811) | 2.62972921 |
| 73 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.58189533 |
| 74 | type I interferon signaling pathway (GO:0060337) | 2.57606082 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.57606082 |
| 76 | regulation of glycogen biosynthetic process (GO:0005979) | 2.57457064 |
| 77 | regulation of glucan biosynthetic process (GO:0010962) | 2.57457064 |
| 78 | cellular response to interleukin-6 (GO:0071354) | 2.55750339 |
| 79 | regulation of activation of Janus kinase activity (GO:0010533) | 2.52137068 |
| 80 | response to type I interferon (GO:0034340) | 2.49972077 |
| 81 | glycosaminoglycan catabolic process (GO:0006027) | 2.48625872 |
| 82 | dendritic cell migration (GO:0036336) | 2.47068930 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46095573 |
| 84 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.45600136 |
| 85 | glycosaminoglycan biosynthetic process (GO:0006024) | 2.44757093 |
| 86 | behavioral response to ethanol (GO:0048149) | 2.43857730 |
| 87 | membrane assembly (GO:0071709) | 2.43774660 |
| 88 | histone H3-K36 demethylation (GO:0070544) | 2.42041787 |
| 89 | response to cadmium ion (GO:0046686) | 2.40006222 |
| 90 | aminoglycan catabolic process (GO:0006026) | 2.39890199 |
| 91 | substrate-dependent cell migration (GO:0006929) | 2.39210172 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.38893921 |
| 93 | protein carboxylation (GO:0018214) | 2.38893921 |
| 94 | aminoglycan biosynthetic process (GO:0006023) | 2.38726784 |
| 95 | response to interferon-alpha (GO:0035455) | 2.37985532 |
| 96 | quinone metabolic process (GO:1901661) | 2.37746848 |
| 97 | response to copper ion (GO:0046688) | 2.36551082 |
| 98 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.36344135 |
| 99 | positive regulation of respiratory burst (GO:0060267) | 18.0192433 |
| 100 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 10.3747229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.10988564 |
| 2 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.88265034 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.53620779 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.18829602 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93874699 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.83953878 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.31637024 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.27378266 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.21937207 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21008967 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10652333 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.07831801 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 11.9779795 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97909590 |
| 15 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.97815331 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96032849 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.92543712 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89540128 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87552662 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87118117 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86988542 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.83288396 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82240262 |
| 24 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79366484 |
| 25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79366484 |
| 26 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75973026 |
| 27 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.72035858 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.53695016 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44401445 |
| 30 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40455325 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37700060 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35694359 |
| 33 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32650736 |
| 34 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.32611240 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.29201026 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27953645 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27426975 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18470957 |
| 39 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.16142884 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15498687 |
| 41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14667893 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14653670 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12962195 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12576185 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11323255 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10299295 |
| 47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09832170 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09287710 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07193302 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00775366 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00228244 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99769197 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99437609 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.94764840 |
| 55 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93957263 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92897671 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90144064 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89171599 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87256905 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86960802 |
| 61 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86927980 |
| 62 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.85722774 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85622019 |
| 64 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85552227 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 0.84610218 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84463528 |
| 67 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84459060 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.83057792 |
| 69 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82928414 |
| 70 | * P300_27268052_Chip-Seq_Bcells_Human | 0.80421028 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80392856 |
| 72 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79096363 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78298832 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78239251 |
| 75 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.77752937 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77406877 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76713366 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.76473611 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76269547 |
| 80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74046487 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.73856440 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73237202 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71085878 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70381516 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69915496 |
| 86 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.69325571 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69286585 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.68806008 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.67977910 |
| 90 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.67813499 |
| 91 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.67611569 |
| 92 | * GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.66914064 |
| 93 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.65410161 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.64839169 |
| 95 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.64069143 |
| 96 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.64019356 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63792715 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63411590 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63234149 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.62222773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005084_abnormal_gallbladder_morpholo | 5.50461355 |
| 2 | MP0005275_abnormal_skin_tensile | 4.90965322 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.70412463 |
| 4 | MP0005365_abnormal_bile_salt | 4.00938753 |
| 5 | MP0004147_increased_porphyrin_level | 3.58249135 |
| 6 | MP0003941_abnormal_skin_development | 3.03723998 |
| 7 | MP0002108_abnormal_muscle_morphology | 2.95881711 |
| 8 | MP0003950_abnormal_plasma_membrane | 2.93689445 |
| 9 | MP0005623_abnormal_meninges_morphology | 2.66872324 |
| 10 | MP0005508_abnormal_skeleton_morphology | 2.46112675 |
| 11 | MP0009764_decreased_sensitivity_to | 2.26263081 |
| 12 | MP0005503_abnormal_tendon_morphology | 10.1676875 |
| 13 | MP0003724_increased_susceptibility_to | 1.98713728 |
| 14 | MP0000749_muscle_degeneration | 1.97090159 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.78872456 |
| 16 | MP0000751_myopathy | 1.75017247 |
| 17 | MP0003385_abnormal_body_wall | 1.72810963 |
| 18 | MP0004272_abnormal_basement_membrane | 1.71775832 |
| 19 | MP0001346_abnormal_lacrimal_gland | 1.69752594 |
| 20 | MP0003075_altered_response_to | 1.57155044 |
| 21 | MP0010386_abnormal_urinary_bladder | 1.48749371 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 1.48033595 |
| 23 | MP0003252_abnormal_bile_duct | 1.47239992 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.46441824 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.37972562 |
| 26 | MP0005390_skeleton_phenotype | 1.36710404 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.29875377 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.29002140 |
| 29 | MP0005023_abnormal_wound_healing | 1.27184292 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.22063170 |
| 31 | MP0005165_increased_susceptibility_to | 1.20005887 |
| 32 | MP0000685_abnormal_immune_system | 1.19309922 |
| 33 | MP0001958_emphysema | 1.16445307 |
| 34 | MP0001756_abnormal_urination | 1.12174556 |
| 35 | MP0005451_abnormal_body_composition | 1.12102132 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.11124737 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.08182780 |
| 38 | MP0001293_anophthalmia | 1.06942631 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.04104765 |
| 40 | MP0001790_abnormal_immune_system | 1.03605422 |
| 41 | MP0005387_immune_system_phenotype | 1.03605422 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.03422859 |
| 43 | MP0000613_abnormal_salivary_gland | 1.02325627 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 1.00195011 |
| 45 | MP0008961_abnormal_basal_metabolism | 0.99908512 |
| 46 | MP0002249_abnormal_larynx_morphology | 0.99778458 |
| 47 | MP0005171_absent_coat_pigmentation | 0.99686526 |
| 48 | MP0002998_abnormal_bone_remodeling | 0.96135369 |
| 49 | MP0002115_abnormal_skeleton_extremities | 0.94299754 |
| 50 | MP0009672_abnormal_birth_weight | 0.91421327 |
| 51 | MP0000163_abnormal_cartilage_morphology | 0.90448931 |
| 52 | MP0001243_abnormal_dermal_layer | 0.90143925 |
| 53 | MP0006054_spinal_hemorrhage | 0.89630350 |
| 54 | MP0005257_abnormal_intraocular_pressure | 0.87455060 |
| 55 | MP0003279_aneurysm | 0.86001565 |
| 56 | MP0003938_abnormal_ear_development | 0.85510047 |
| 57 | MP0008260_abnormal_autophagy | 0.79884816 |
| 58 | MP0001348_abnormal_lacrimal_gland | 0.77102497 |
| 59 | MP0000920_abnormal_myelination | 0.75813297 |
| 60 | MP0009703_decreased_birth_body | 0.73957022 |
| 61 | MP0002113_abnormal_skeleton_development | 0.73049814 |
| 62 | MP0000538_abnormal_urinary_bladder | 0.70606436 |
| 63 | MP0001286_abnormal_eye_development | 0.70566851 |
| 64 | MP0000858_altered_metastatic_potential | 0.70294964 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 0.69301916 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.68513278 |
| 67 | MP0003122_maternal_imprinting | 0.66638963 |
| 68 | MP0002419_abnormal_innate_immunity | 0.66481977 |
| 69 | MP0005334_abnormal_fat_pad | 0.64635779 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 0.64608715 |
| 71 | MP0002060_abnormal_skin_morphology | 0.61103205 |
| 72 | MP0000358_abnormal_cell_content/ | 0.59946305 |
| 73 | MP0000470_abnormal_stomach_morphology | 0.58695675 |
| 74 | MP0000534_abnormal_ureter_morphology | 0.57853969 |
| 75 | MP0002109_abnormal_limb_morphology | 0.57623882 |
| 76 | MP0009785_altered_susceptibility_to | 0.56597352 |
| 77 | MP0002092_abnormal_eye_morphology | 0.55312529 |
| 78 | MP0002163_abnormal_gland_morphology | 0.54631002 |
| 79 | MP0001119_abnormal_female_reproductive | 0.54296242 |
| 80 | MP0005671_abnormal_response_to | 0.53071802 |
| 81 | MP0003091_abnormal_cell_migration | 0.52915438 |
| 82 | MP0000627_abnormal_mammary_gland | 0.51474883 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.51077518 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.49527699 |
| 85 | MP0000681_abnormal_thyroid_gland | 0.48731989 |
| 86 | MP0002933_joint_inflammation | 0.48455536 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.48347064 |
| 88 | MP0008469_abnormal_protein_level | 0.48166464 |
| 89 | MP0003795_abnormal_bone_structure | 0.46890192 |
| 90 | MP0002272_abnormal_nervous_system | 0.46781623 |
| 91 | MP0001835_abnormal_antigen_presentation | 0.45653148 |
| 92 | MP0005025_abnormal_response_to | 0.45469032 |
| 93 | MP0000249_abnormal_blood_vessel | 0.45454861 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.44837719 |
| 95 | MP0002168_other_aberrant_phenotype | 0.44342571 |
| 96 | MP0003011_delayed_dark_adaptation | 0.43698514 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.42915523 |
| 98 | MP0003879_abnormal_hair_cell | 0.42558027 |
| 99 | MP0005369_muscle_phenotype | 0.41304217 |
| 100 | MP0009643_abnormal_urine_homeostasis | 0.40665655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neonatal short-limb short stature (HP:0008921) | 7.97330259 |
| 2 | Ileus (HP:0002595) | 7.21458478 |
| 3 | Pancreatic islet-cell hyperplasia (HP:0004510) | 6.92070680 |
| 4 | Long foot (HP:0001833) | 6.58357100 |
| 5 | Chronic hepatic failure (HP:0100626) | 6.16203837 |
| 6 | Hypoglycemic seizures (HP:0002173) | 5.94671304 |
| 7 | Enlarged penis (HP:0000040) | 5.91018749 |
| 8 | Thick nail (HP:0001805) | 5.89396793 |
| 9 | Advanced eruption of teeth (HP:0006288) | 5.79181634 |
| 10 | Conical tooth (HP:0000698) | 5.78977410 |
| 11 | Natal tooth (HP:0000695) | 5.60686067 |
| 12 | Abnormal number of incisors (HP:0011064) | 5.58155905 |
| 13 | Congenital, generalized hypertrichosis (HP:0004540) | 5.19198458 |
| 14 | Mild short stature (HP:0003502) | 5.12467031 |
| 15 | Elfin facies (HP:0004428) | 5.11887628 |
| 16 | Retinal dysplasia (HP:0007973) | 5.09109790 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.95194925 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.94061467 |
| 19 | Scanning speech (HP:0002168) | 4.38245207 |
| 20 | Symptomatic seizures (HP:0011145) | 4.30394003 |
| 21 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.25585318 |
| 22 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.25585318 |
| 23 | Amyloidosis (HP:0011034) | 4.07347383 |
| 24 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.91420793 |
| 25 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.81406448 |
| 26 | Protruding tongue (HP:0010808) | 3.79647371 |
| 27 | Growth hormone excess (HP:0000845) | 3.78179008 |
| 28 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 3.67195258 |
| 29 | Bulbar palsy (HP:0001283) | 3.27898954 |
| 30 | Abnormality of the dental pulp (HP:0006479) | 3.22459403 |
| 31 | Abnormality of the dental root (HP:0006486) | 3.22434158 |
| 32 | Taurodontia (HP:0000679) | 3.22434158 |
| 33 | Abnormality of permanent molar morphology (HP:0011071) | 3.22434158 |
| 34 | Facial cleft (HP:0002006) | 3.20494984 |
| 35 | Abnormality of molar (HP:0011077) | 3.09598158 |
| 36 | Abnormality of molar morphology (HP:0011070) | 3.09598158 |
| 37 | Ketoacidosis (HP:0001993) | 3.09437910 |
| 38 | Hyperglycemia (HP:0003074) | 2.96993862 |
| 39 | Dysmetric saccades (HP:0000641) | 2.93001992 |
| 40 | Large hands (HP:0001176) | 2.90135202 |
| 41 | Abnormality of the incisor (HP:0000676) | 2.86846379 |
| 42 | Right ventricular cardiomyopathy (HP:0011663) | 2.84141420 |
| 43 | Insulin resistance (HP:0000855) | 2.83551742 |
| 44 | Abnormality of the alveolar ridges (HP:0006477) | 2.83289408 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.82034286 |
| 46 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.81667797 |
| 47 | Intellectual disability, moderate (HP:0002342) | 2.79609628 |
| 48 | Clitoromegaly (HP:0000057) | 2.78229424 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.68429979 |
| 50 | Acanthosis nigricans (HP:0000956) | 2.67305873 |
| 51 | Synostosis of carpal bones (HP:0005048) | 2.58502135 |
| 52 | Neoplasm of the liver (HP:0002896) | 2.54681549 |
| 53 | Diaphragmatic weakness (HP:0009113) | 2.53936231 |
| 54 | Cubitus valgus (HP:0002967) | 2.52772308 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.47599223 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.47599223 |
| 57 | Complete atrioventricular canal defect (HP:0001674) | 2.46714667 |
| 58 | Spinal rigidity (HP:0003306) | 2.44840769 |
| 59 | Carpal synostosis (HP:0009702) | 2.42620353 |
| 60 | Gastrointestinal dysmotility (HP:0002579) | 2.38317607 |
| 61 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.34882436 |
| 62 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.33687457 |
| 63 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 2.24011708 |
| 64 | Tachypnea (HP:0002789) | 2.12344721 |
| 65 | Optic nerve coloboma (HP:0000588) | 2.11363817 |
| 66 | Portal hypertension (HP:0001409) | 2.11273725 |
| 67 | Emphysema (HP:0002097) | 2.06282626 |
| 68 | Abnormality of the antihelix (HP:0009738) | 2.04702222 |
| 69 | Genetic anticipation (HP:0003743) | 2.03780113 |
| 70 | Abnormality of saccadic eye movements (HP:0000570) | 2.00476514 |
| 71 | Synostosis involving bones of the hand (HP:0004278) | 1.98719801 |
| 72 | Abnormality of the hepatic vasculature (HP:0006707) | 1.98195422 |
| 73 | Slow saccadic eye movements (HP:0000514) | 1.96461300 |
| 74 | Self-mutilation (HP:0000742) | 1.94303928 |
| 75 | Microdontia (HP:0000691) | 1.94295835 |
| 76 | Postaxial foot polydactyly (HP:0001830) | 1.93899061 |
| 77 | Bradycardia (HP:0001662) | 1.92410575 |
| 78 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.88313843 |
| 79 | Follicular hyperkeratosis (HP:0007502) | 1.87134422 |
| 80 | Eosinophilia (HP:0001880) | 1.83613153 |
| 81 | Esophageal neoplasm (HP:0100751) | 1.82234958 |
| 82 | Neoplasm of head and neck (HP:0012288) | 1.82234958 |
| 83 | Insomnia (HP:0100785) | 1.81626401 |
| 84 | Type 1 muscle fiber predominance (HP:0003803) | 1.81261132 |
| 85 | Slender build (HP:0001533) | 1.79301658 |
| 86 | Corneal dystrophy (HP:0001131) | 1.78878767 |
| 87 | Ankle contracture (HP:0006466) | 1.77126065 |
| 88 | Subacute progressive viral hepatitis (HP:0006572) | 1.73381044 |
| 89 | Atrioventricular canal defect (HP:0006695) | 1.73298578 |
| 90 | Retrobulbar optic neuritis (HP:0100654) | 1.72093856 |
| 91 | Optic neuritis (HP:0100653) | 1.72093856 |
| 92 | Abnormality of the clitoris (HP:0000056) | 1.71969258 |
| 93 | Ketosis (HP:0001946) | 1.71627896 |
| 94 | Orchitis (HP:0100796) | 1.70632058 |
| 95 | Pulmonary artery stenosis (HP:0004415) | 1.65782104 |
| 96 | Cervical subluxation (HP:0003308) | 1.61185568 |
| 97 | Ventricular tachycardia (HP:0004756) | 1.56869391 |
| 98 | Short tibia (HP:0005736) | 1.47004597 |
| 99 | Hyperpituitarism (HP:0010514) | 1.46249914 |
| 100 | Nausea (HP:0002018) | 1.45638501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRPM7 | 4.46743966 |
| 2 | MAP2K7 | 2.60263232 |
| 3 | PINK1 | 2.53788259 |
| 4 | EPHA3 | 2.19895624 |
| 5 | INSRR | 14.1312752 |
| 6 | PDGFRA | 1.92289099 |
| 7 | FLT3 | 1.78109106 |
| 8 | NTRK1 | 1.70181019 |
| 9 | MAP3K5 | 1.66184766 |
| 10 | ZAK | 1.63615127 |
| 11 | CSK | 1.37478179 |
| 12 | CCNB1 | 1.35642416 |
| 13 | MAP3K4 | 1.33381289 |
| 14 | EPHB1 | 1.31420096 |
| 15 | MET | 1.30269162 |
| 16 | TNK2 | 1.19170211 |
| 17 | PRPF4B | 1.01894499 |
| 18 | FGFR4 | 1.01850247 |
| 19 | NLK | 0.94878471 |
| 20 | DYRK2 | 0.94394407 |
| 21 | TYK2 | 0.89705992 |
| 22 | JAK3 | 0.85055465 |
| 23 | JAK1 | 0.76138072 |
| 24 | BMPR2 | 0.75988637 |
| 25 | ERBB3 | 0.73235891 |
| 26 | TXK | 0.69790063 |
| 27 | MAP2K4 | 0.65900645 |
| 28 | MAP3K14 | 0.64200815 |
| 29 | CASK | 0.61671800 |
| 30 | STK24 | 0.59380205 |
| 31 | BCR | 0.58304606 |
| 32 | MOS | 0.57323409 |
| 33 | FER | 0.55349103 |
| 34 | STK38L | 0.53365891 |
| 35 | PRKCH | 0.53010737 |
| 36 | MAPK13 | 0.52911835 |
| 37 | PDGFRB | 0.48032375 |
| 38 | TAOK3 | 0.45595179 |
| 39 | ZAP70 | 0.42383843 |
| 40 | IRAK1 | 0.41861905 |
| 41 | VRK1 | 0.39882674 |
| 42 | EIF2AK3 | 0.39103342 |
| 43 | MAP2K2 | 0.37335704 |
| 44 | NTRK3 | 0.36905089 |
| 45 | PLK2 | 0.35975459 |
| 46 | EPHB2 | 0.35629052 |
| 47 | IGF1R | 0.34197560 |
| 48 | SGK2 | 0.33284636 |
| 49 | LATS2 | 0.30819763 |
| 50 | TGFBR2 | 0.29936881 |
| 51 | LYN | 0.29577828 |
| 52 | RET | 0.29548250 |
| 53 | IKBKB | 0.29227804 |
| 54 | MAP3K13 | 0.29128465 |
| 55 | PRKCE | 0.26672175 |
| 56 | MAP3K12 | 0.24875478 |
| 57 | TNIK | 0.24596429 |
| 58 | TIE1 | 0.24260405 |
| 59 | PAK6 | 0.23862928 |
| 60 | HIPK2 | 0.23772881 |
| 61 | PLK4 | 0.23754951 |
| 62 | EIF2AK1 | 0.23739230 |
| 63 | CAMKK2 | 0.23729933 |
| 64 | CAMK1G | 0.21676480 |
| 65 | SGK494 | 0.21448386 |
| 66 | SGK223 | 0.21448386 |
| 67 | GRK1 | 0.21293868 |
| 68 | IRAK3 | 0.19982759 |
| 69 | MAP3K1 | 0.19276811 |
| 70 | LCK | 0.18861851 |
| 71 | EIF2AK2 | 0.18581353 |
| 72 | TAOK2 | 0.18437609 |
| 73 | PKN1 | 0.18008196 |
| 74 | MAPK3 | 0.17186176 |
| 75 | INSR | 0.17019899 |
| 76 | SGK3 | 0.16822687 |
| 77 | RIPK4 | 0.16588282 |
| 78 | ALK | 0.16110244 |
| 79 | FGFR3 | 0.15375039 |
| 80 | SRC | 0.15190863 |
| 81 | MAPK4 | 0.14145030 |
| 82 | MAPK10 | 0.13902257 |
| 83 | MAPKAPK2 | 0.13896574 |
| 84 | PTK2 | 0.12572120 |
| 85 | MAPK12 | 0.12044404 |
| 86 | JAK2 | 0.10249840 |
| 87 | MAPK9 | 0.09887473 |
| 88 | PRKACA | 0.09610704 |
| 89 | CHUK | 0.09232410 |
| 90 | PRKCD | 0.08764628 |
| 91 | MAPK15 | 0.08600204 |
| 92 | DAPK2 | 0.08239612 |
| 93 | PAK2 | 0.08176272 |
| 94 | MAPK14 | 0.07211934 |
| 95 | SYK | 0.06975394 |
| 96 | HCK | 0.06729884 |
| 97 | NEK6 | 0.06604585 |
| 98 | CAMK2D | 0.06490130 |
| 99 | YES1 | 0.05841688 |
| 100 | MAP3K3 | 0.05830891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.39853746 |
| 2 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 3.37501316 |
| 3 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.26184117 |
| 4 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.16470464 |
| 5 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.75444319 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.64919862 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.57987465 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.41281023 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.01741780 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92780157 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82435758 |
| 12 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.66602360 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.52119038 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.51564357 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51437484 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45324634 |
| 17 | Mineral absorption_Homo sapiens_hsa04978 | 1.40332446 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.30766693 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.24493186 |
| 20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24435850 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23007547 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22657625 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.22390698 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.20342369 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15711015 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.13138147 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12188411 |
| 28 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08987561 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08102642 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.05867269 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05047288 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03711600 |
| 33 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.02957463 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02565853 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99936495 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98070689 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96170814 |
| 38 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92859979 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89950344 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89478799 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85660578 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82504067 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81352994 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79692800 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76575933 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 0.75711647 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75642173 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73720211 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72995647 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72609396 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71908852 |
| 52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71545393 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70599108 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.68547420 |
| 55 | Prostate cancer_Homo sapiens_hsa05215 | 0.67608015 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66858631 |
| 57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66656341 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.66011986 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65691637 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.62573172 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61266533 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.60445611 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.59970195 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.58813052 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57344707 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.57204505 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56111704 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55105747 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52699732 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52501966 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51907020 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50461664 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49568342 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48942214 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48909552 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.47796986 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47681212 |
| 78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46916935 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.46858810 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46852149 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.45588217 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44949595 |
| 83 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44404348 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43359425 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42577546 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42423904 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41674475 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41004873 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39199085 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38779459 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38656522 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38557613 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38037729 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37777394 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37182861 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37131696 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.35760572 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35576328 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35196934 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33969526 |

